IL138906A0
(en )
2001-11-25
Quinolones used as mrs inhibitors and bactericides
ZA200204390B
(en )
2003-08-27
Caspase inhibitors and uses thereof.
HK1061851A1
(en )
2004-10-08
Gyrase inhibitors and uses thereof
IL173393A0
(en )
2006-06-11
4-carboxyamino-2- substituted-1,2,3,4- tetrahydroquinolines as cetp inhibitors
SI1114033T1
(en )
2005-02-28
4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as cetp inhibitors
IL128663A0
(en )
2000-01-31
1,4-heterocyclic metalloprotease inhibitors
SI1251848T1
(en )
2004-12-31
Gyrase inhibitors and uses thereof
ZA200006577B
(en )
2002-04-24
Phthalazine derivatives as phosphodiesterase 4 inhibitors.
IL128661A0
(en )
2000-01-31
1,3-diheterocyclic metalloprotease inhibitors
IL144214A0
(en )
2002-05-23
Benzoheterocycles and their use as mek inhibitors
ZA991951B
(en )
1999-08-16
Compound and its use.
GB9900416D0
(en )
1999-02-24
Inhibitors
HK1047743A1
(en )
2003-03-07
New use and novel n-azabicyclo-amide derivatives.
HK1040253A1
(en )
2002-05-31
Factor viia inhibitors.
ZA977697B
(en )
1998-02-23
Bidentate metalloprotease inhibitors.
HUP0103473A3
(en )
2003-01-28
Phosphoglycolipid and methods for its use
PL353214A1
(en )
2003-11-03
Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
EP1153022A4
(en )
2002-03-27
Prothease inhibitors
ZA200006020B
(en )
2001-06-25
Voacamine as anti-malarial agent and anti-malarial agent containing voacamine.
EP1047942A4
(en )
2002-10-30
Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
MXPA03005395A
(en )
2003-09-25
Dihydroindole and tetrahydroquinoline derivatives.
ZA200005781B
(en )
2001-06-04
Quinolones used as mrs inhibitors and bactericides.
SI1214302T1
(en )
2004-04-30
Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-ones and their use as lipase inhibitors
ZA200105277B
(en )
2002-12-24
New amidinobenzylamine derivatives and their use as thrombin inhibitors.
AU6976400A
(en )
2001-04-10
1,2,3-thiadiazoles and their use as cox-2 inhibitors